Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

NCT03117998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Type1 Diabetes Mellitus

Interventions

BIOLOGICAL: REMD-477
BIOLOGICAL: Placebo Comparator

Sponsor

REMD Biotherapeutics, Inc.